Gedeon Richter PLC (BUD:RICHTER)

Market Cap	2.33T +22.3%
Revenue (ttm)	925.05B +2.4%
Net Income	215.91B -2.3%
EPS	1,180.33 -2.3%
Shares Out	182.39M
PE Ratio	10.84
Forward PE	8.12
Dividend	655.45 (5.00%)
Ex-Dividend Date	Jun 3, 2026

Volume	375,193
Open	13,100
Previous Close	13,110
Day's Range	12,750 - 13,120
52-Week Range	9,380 - 13,570
Beta	0.34
Analysts	Buy
Price Target	12,957.43 (+1.23%)
Earnings Date	Aug 7, 2026

About Gedeon Richter

Gedeon Richter PLC researches, develops, manufactures, markets, and sells pharmaceutical products. It offers women’s healthcare products for contraceptives, endometriosis, fertility, menopause, vaginal infections, and uterine fibroids; and Femtech, a digital therapeutic solution to enhance women’s lives. It also provides central nervous system products, such as products for the treatment of chronic cerebral circulatory disorders and neuropathic pain; and anaesthetics, anti-anxiety medications, sleeping pills, and anti-epileptic medicines, as we...

• Industry: Pharmaceutical Preparations
• Founded: 1901
• Employees: 11,155
• Stock Exchange: Budapest Stock Exchange
• Ticker Symbol: RICHTER

Financial Performance

In 2025, Gedeon Richter's revenue was 928.96 billion, an increase of 8.33% compared to the previous year's 857.55 billion. Earnings were 232.34 billion, a decrease of -2.89%.

Analyst Summary

According to 7 analysts, the average rating for RICHTER stock is "Buy." The 12-month stock price target is Ft 12,957, which is an increase of 1.23% from the latest price.

Price Target

Ft 12,957

(1.23% upside)

Analyst Consensus: Buy

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Sep 3, 2026

Data Sources Report a data error